07
Feb

Over the past few years, the FDA has unveiled a spate of new approval pathways in hopes of getting much-needed treatments on the market faster. But in the rush to accelerate drug development, the agency has wound up putting patients at risk, according to one congresswoman, fast-tracking unproven therapies despite serious safety concerns.

…read more

Source: U.S. rep rips the FDA’s efforts to speed up drug approvals

    

0 No comments